EPP

Clinical trials for EPP explained in plain language.

Never miss a new study

Get alerted when new EPP trials appear

Sign up with your email to follow new studies for EPP, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Extended safety check for promising light-sensitivity pill

Disease control Recruiting now

This study follows people who have already taken the experimental drug dersimelagon in previous trials to check its long-term safety. It's for adults and adolescents with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP)—rare disorders causing severe pain from …

Matched conditions: EPP

Phase: PHASE3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Disease control

Last updated Apr 02, 2026 02:26 UTC

EPP

Get alerted when new EPP trials appear

Extended safety check for promising light-sensitivity pill